Happiest Minds Technologies Earnings Call Transcripts
Fiscal Year 2026
-
Q3 saw 2.4% sequential and 10.7% YoY revenue growth, with strong AI-led execution and margin improvement. AI First strategy is driving customer adoption, especially in BFSI and healthcare, and management remains confident in 10%+ growth, with higher guidance possible after Q4.
-
Delivered 11.8% constant currency revenue growth and 20.8% EBITDA margin in H1 FY26, led by rapid expansion in Generative AI services and strong new client wins. Raised growth outlook to four years of double-digit growth, with continued focus on AI, cloud, and cybersecurity.
-
Q1 FY26 saw 17.5% year-over-year growth and 21.4% EBITDA margin, with strong GenAI and BFSI performance. Double-digit growth and 20–22% EBITDA margin are targeted for FY26, supported by a robust pipeline and ongoing strategic investments.
Fiscal Year 2025
-
Achieved 25.6% constant currency revenue growth for FY 2025, driven by acquisitions and transformational initiatives. BFSI and healthcare are key growth areas, with strong GenAI momentum and a robust outlook for double-digit organic growth in FY 2026 and FY 2027.
-
Q3 saw 28.5% YoY revenue growth, strong margins, and robust deal momentum, led by BFSI and healthcare. Acquisitions and GenAI investments are driving future growth, with double-digit organic growth targeted next year.
-
Achieved 12.7% QoQ and 28.2% YoY revenue growth, driven by acquisitions, Gen AI, and strong BFSI/healthcare performance. Margins remain within 20%-22% guidance despite investments and wage hikes. Outlook is positive, with Q4 expected to be stronger due to large deal closures.
-
Q1 FY25 saw double-digit revenue growth, strong EBITDA margins, and successful integration of two major acquisitions. The company maintained its EBITDA margin guidance and revised revenue growth forecast to 30%-35% for FY25, with continued investment in GenAI and new markets.